vs
Side-by-side financial comparison of Commerce.com, Inc. (CMRC) and Esperion Therapeutics, Inc. (ESPR). Click either name above to swap in a different company.
Esperion Therapeutics, Inc. is the larger business by last-quarter revenue ($168.4M vs $89.5M, roughly 1.9× Commerce.com, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 2.9%). Over the past eight quarters, Esperion Therapeutics, Inc.'s revenue compounded faster (10.6% CAGR vs 5.5%).
SPS Commerce, Inc. is a technology and application software company based in the United States that provides cloud-based supply chain management software. The company's headquarters are located in Minneapolis, Minnesota, but it also has a US office in New Jersey, and international locations in Amsterdam, Beijing, Breukelen, Hong Kong, Kyiv, Melbourne, Montpellier, Sydney, and Toronto.
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
CMRC vs ESPR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $89.5M | $168.4M |
| Net Profit | $-8.4M | — |
| Gross Margin | 78.3% | — |
| Operating Margin | -7.4% | 50.6% |
| Net Margin | -9.3% | — |
| Revenue YoY | 2.9% | 143.7% |
| Net Profit YoY | -250.0% | — |
| EPS (diluted) | $-0.11 | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $89.5M | $168.4M | ||
| Q3 25 | $86.0M | $87.3M | ||
| Q2 25 | $84.4M | $82.4M | ||
| Q1 25 | $82.4M | $65.0M | ||
| Q4 24 | $87.0M | $69.1M | ||
| Q3 24 | $83.7M | $51.6M | ||
| Q2 24 | $81.8M | $73.8M | ||
| Q1 24 | $80.4M | $137.7M |
| Q4 25 | $-8.4M | — | ||
| Q3 25 | $-2.2M | $-31.3M | ||
| Q2 25 | $-8.4M | $-12.7M | ||
| Q1 25 | $-353.0K | $-40.5M | ||
| Q4 24 | $-2.4M | — | ||
| Q3 24 | $-7.0M | $-29.5M | ||
| Q2 24 | $-11.3M | $-61.9M | ||
| Q1 24 | $-6.4M | $61.0M |
| Q4 25 | 78.3% | — | ||
| Q3 25 | 78.4% | — | ||
| Q2 25 | 79.0% | — | ||
| Q1 25 | 79.4% | — | ||
| Q4 24 | 77.6% | — | ||
| Q3 24 | 76.3% | — | ||
| Q2 24 | 75.8% | — | ||
| Q1 24 | 77.1% | — |
| Q4 25 | -7.4% | 50.6% | ||
| Q3 25 | -0.5% | -11.4% | ||
| Q2 25 | -8.0% | 8.6% | ||
| Q1 25 | -2.9% | -34.0% | ||
| Q4 24 | -0.9% | -6.4% | ||
| Q3 24 | -23.0% | -31.0% | ||
| Q2 24 | -16.5% | 3.5% | ||
| Q1 24 | -10.2% | 52.5% |
| Q4 25 | -9.3% | — | ||
| Q3 25 | -2.6% | -35.9% | ||
| Q2 25 | -9.9% | -15.4% | ||
| Q1 25 | -0.4% | -62.2% | ||
| Q4 24 | -2.7% | — | ||
| Q3 24 | -8.4% | -57.2% | ||
| Q2 24 | -13.8% | -83.9% | ||
| Q1 24 | -8.0% | 44.3% |
| Q4 25 | $-0.11 | $0.32 | ||
| Q3 25 | $-0.03 | $-0.16 | ||
| Q2 25 | $-0.10 | $-0.06 | ||
| Q1 25 | $0.00 | $-0.21 | ||
| Q4 24 | $-0.03 | $-0.14 | ||
| Q3 24 | $-0.09 | $-0.15 | ||
| Q2 24 | $-0.15 | $-0.33 | ||
| Q1 24 | $-0.08 | $0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $141.1M | $167.9M |
| Total DebtLower is stronger | $157.0M | — |
| Stockholders' EquityBook value | $39.4M | $-302.0M |
| Total Assets | $308.8M | $465.9M |
| Debt / EquityLower = less leverage | 3.99× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $141.1M | $167.9M | ||
| Q3 25 | $142.0M | $92.4M | ||
| Q2 25 | $134.5M | $86.1M | ||
| Q1 25 | $120.7M | $114.6M | ||
| Q4 24 | $178.2M | $144.8M | ||
| Q3 24 | $168.4M | $144.7M | ||
| Q2 24 | $275.8M | $189.3M | ||
| Q1 24 | $265.2M | $226.6M |
| Q4 25 | $157.0M | — | ||
| Q3 25 | $157.3M | — | ||
| Q2 25 | $157.5M | — | ||
| Q1 25 | $157.8M | — | ||
| Q4 24 | $216.5M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $340.9M | — | ||
| Q1 24 | $340.5M | — |
| Q4 25 | $39.4M | $-302.0M | ||
| Q3 25 | $42.8M | $-451.4M | ||
| Q2 25 | $38.8M | $-433.5M | ||
| Q1 25 | $38.1M | $-426.2M | ||
| Q4 24 | $33.4M | $-388.7M | ||
| Q3 24 | $29.0M | $-370.2M | ||
| Q2 24 | $26.1M | $-344.2M | ||
| Q1 24 | $26.9M | $-294.3M |
| Q4 25 | $308.8M | $465.9M | ||
| Q3 25 | $309.5M | $364.0M | ||
| Q2 25 | $302.5M | $347.1M | ||
| Q1 25 | $286.3M | $324.0M | ||
| Q4 24 | $340.3M | $343.8M | ||
| Q3 24 | $335.1M | $314.1M | ||
| Q2 24 | $452.5M | $352.3M | ||
| Q1 24 | $442.5M | $373.1M |
| Q4 25 | 3.99× | — | ||
| Q3 25 | 3.67× | — | ||
| Q2 25 | 4.06× | — | ||
| Q1 25 | 4.14× | — | ||
| Q4 24 | 6.49× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 13.06× | — | ||
| Q1 24 | 12.65× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $980.0K | $45.2M |
| Free Cash FlowOCF − Capex | $-2.2M | — |
| FCF MarginFCF / Revenue | -2.4% | — |
| Capex IntensityCapex / Revenue | 3.5% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $16.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $980.0K | $45.2M | ||
| Q3 25 | $10.6M | $-4.3M | ||
| Q2 25 | $13.6M | $-31.4M | ||
| Q1 25 | $401.0K | $-22.6M | ||
| Q4 24 | $12.4M | $-35.0M | ||
| Q3 24 | $5.6M | $-35.3M | ||
| Q2 24 | $11.7M | $-7.2M | ||
| Q1 24 | $-3.4M | $53.8M |
| Q4 25 | $-2.2M | — | ||
| Q3 25 | $7.6M | — | ||
| Q2 25 | $11.9M | — | ||
| Q1 25 | $-424.0K | — | ||
| Q4 24 | $11.6M | — | ||
| Q3 24 | $4.5M | $-35.5M | ||
| Q2 24 | $10.7M | $-7.3M | ||
| Q1 24 | $-4.2M | $53.8M |
| Q4 25 | -2.4% | — | ||
| Q3 25 | 8.8% | — | ||
| Q2 25 | 14.1% | — | ||
| Q1 25 | -0.5% | — | ||
| Q4 24 | 13.3% | — | ||
| Q3 24 | 5.4% | -68.7% | ||
| Q2 24 | 13.0% | -9.9% | ||
| Q1 24 | -5.3% | 39.0% |
| Q4 25 | 3.5% | 0.0% | ||
| Q3 25 | 3.4% | 0.0% | ||
| Q2 25 | 2.0% | 0.0% | ||
| Q1 25 | 1.0% | 0.0% | ||
| Q4 24 | 0.9% | 0.0% | ||
| Q3 24 | 1.3% | 0.3% | ||
| Q2 24 | 1.3% | 0.1% | ||
| Q1 24 | 1.0% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.88× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CMRC
| Subscription And Circulation | $65.2M | 73% |
| Partner And Services | $24.4M | 27% |
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
